65 filings
8-K
TELA
TELA Bio Inc
20 May 24
TELA Bio Appoints Greg Firestone as Chief Commercial Officer
4:15pm
8-K
TELA
TELA Bio Inc
9 May 24
TELA Bio Reports First Quarter 2024 Financial Results
4:20pm
8-K
TELA
TELA Bio Inc
15 Apr 24
Other Events
7:13am
8-K
TELA
TELA Bio Inc
21 Mar 24
TELA Bio Achieves Record Fourth Quarter and Full Year 2023 Revenues and Reports Complete Financial Results
4:15pm
8-K
TELA
TELA Bio Inc
20 Mar 24
TELA Bio Announces Sale of Distribution Rights for Wound Care Product to MIMEDX
7:15am
8-K
mclt0sg6ulxeldrc1u0
9 Nov 23
TELA Bio Reports Third Quarter 2023 Financial Results
4:05pm
8-K
yex7wyfm0g8q
20 Oct 23
Entry into a Material Definitive Agreement
4:06pm
8-K
5nj21a75vgmgm3sl88o3
28 Sep 23
Departure of Directors or Certain Officers
4:05pm
8-K
sbyk7v4jsznzk9u
16 Aug 23
TELA Bio Announces U.S. Commercial Launch of OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
7:15am
8-K
0pzwrlo
9 Aug 23
TELA Bio Reports Second Quarter 2023 Financial Results
4:05pm
8-K
r7w37vhqyhfd ny
2 Jun 23
Submission of Matters to a Vote of Security Holders
4:05pm
8-K
asjpti8e
11 May 23
TELA Bio Reports First Quarter 2023 Financial Results
4:05pm
8-K
0t41 141yrh82k0
20 Apr 23
Entry into a Material Definitive Agreement
4:52pm
8-K
0pf1lanp
18 Apr 23
Results of Operations and Financial Condition
4:03pm
8-K
oeolwhq7 ci
23 Mar 23
TELA Bio Announces 510(k) Clearance for OviTex® PRS Long-Term Resorbable for Plastic and Reconstructive Surgery
7:15am
8-K
rnv3hue n36b44
21 Mar 23
TELA Bio Reports Fourth Quarter and Full Year 2022 Financial Results
4:10pm
8-K
t940xqcfsv3h5z1ep
21 Feb 23
Other Events
7:15am
8-K
sizn mbrj40vkiw
10 Jan 23
INVESTOR PRESENTATION January 2023
7:15am
8-K
y4eeg2idm5ewlf1
9 Jan 23
TELA Bio Announces U.S. Commercial Launch of NIVISTM Fibrillar Collagen Pack, The Natural Restoration Solution to Support Healing of Surgical Wounds
7:15am
8-K
2jotz0wpmn7k5i
9 Nov 22
TELA Bio Reports Third Quarter 2022 Financial Results
4:06pm